These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3341790)

  • 1. [Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
    Miyata T; Masuda H; Inoue T; Saeki K; Torisu M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):297-300. PubMed ID: 3341790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
    Cocconi G; DeLisi V; Di Blasio B
    Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
    Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
    Bilen CY; Inci K; Erkan I; Ozen H
    J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of UFT on lymphocyte subsets and lymphocyte response to PHA].
    Nakao S; Hasegawa H; Ishii T; Eida K; Noguchi K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3157-9. PubMed ID: 3118818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphocyte immunoreactivity in subjects vaccinated with Calmette-Guerin bacillus (BCG)].
    Tartaglino B; Vietti Ramus G; Cesano L; Barbalonga A
    Minerva Med; 1981 Apr; 72(15):929-34. PubMed ID: 7219800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of colorectal cancer. Value of immunologic competence skin tests in the prognostic and immunotherapeutic evaluation].
    de Godoy AC; Crema E; Goffi FS; Aun WC; Salles VL; de Mello JF
    Rev Paul Med; 1983; 101(3):91-5. PubMed ID: 6648227
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced stomach cancer].
    Starzyńska T
    Pol Tyg Lek; 1986 Nov; 41(46):1463-6. PubMed ID: 3550744
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.
    Falk RE; MacGregor AB; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1976 Mar; 142(3):363-8. PubMed ID: 1251316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary research on the evaluation of some prognostic factors in a randomized study of adjuvant immunochemotherapy in colorectal adenocarcinoma.
    Lagomarsino Caprino MC; Mazzei T; De Vecchis L; Popoli P; Periti P
    Chemioterapia; 1984 Feb; 3(1):3-9. PubMed ID: 6442971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
    Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
    Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine.
    Hoover HC; Surdyke M; Dangel RB; Peters LC; Hanna MG
    Cancer Res; 1984 Apr; 44(4):1671-6. PubMed ID: 6704973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.